BRUKER CORPORATION Net Cash Provided by (Used in) Investing Activities, Continuing Operations
BRUKER CORPORATION (BRKR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$71.30 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-10
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$71.30M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$40.30M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $19.00M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $6.90M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$21.80M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$102.40M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$201.90M.
- BRUKER CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$60.00M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$71.30M 10-Q · filed 2017-05-10 | -$111.60M derived: sum of 2 quarters · filed 2017-05-10 | -$92.60M derived: sum of 3 quarters · filed 2017-05-10 | -$85.70M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$40.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$21.30M derived: sum of 2 quarters · filed 2017-03-01 | -$14.40M derived: sum of 3 quarters · filed 2017-03-01 | -$21.80M 10-K · filed 2017-03-01 |
| 2016-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $25.90M derived: sum of 2 quarters · filed 2016-11-09 | $18.50M 10-Q · filed 2016-11-09 | -$25.10M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$500.00K 10-Q · filed 2016-08-05 | -$44.10M derived: sum of 3 quarters · filed 2017-05-10 | -$81.40M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | -$7.40M 10-Q · filed 2017-05-10 | -$51.00M derived: sum of 2 quarters · filed 2017-05-10 | -$88.30M derived: sum of 3 quarters · filed 2017-05-10 | -$104.10M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$43.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$80.90M derived: sum of 2 quarters · filed 2017-03-01 | -$96.70M derived: sum of 3 quarters · filed 2017-03-01 | -$102.40M 10-K · filed 2017-03-01 |
| 2015-09-30 | -$37.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$53.10M derived: sum of 2 quarters · filed 2016-11-09 | -$58.80M 10-Q · filed 2016-11-09 | -$125.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$15.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$21.50M 10-Q · filed 2016-08-05 | -$87.70M derived: sum of 3 quarters · filed 2017-03-01 | -$140.60M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$5.70M 10-Q · filed 2016-05-06 | -$71.90M derived: sum of 2 quarters · filed 2017-03-01 | -$124.80M derived: sum of 3 quarters · filed 2017-03-01 | -$199.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$66.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$119.10M derived: sum of 2 quarters · filed 2017-03-01 | -$194.00M derived: sum of 3 quarters · filed 2017-03-01 | -$201.90M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$52.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$127.80M derived: sum of 2 quarters · filed 2015-11-06 | -$135.70M 10-Q · filed 2015-11-06 | -$144.10M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$74.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$82.80M 10-Q · filed 2015-08-07 | -$91.20M derived: sum of 3 quarters · filed 2016-02-29 | -$110.70M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$7.90M 10-Q · filed 2015-05-08 | -$16.30M derived: sum of 2 quarters · filed 2016-02-29 | -$35.80M derived: sum of 3 quarters · filed 2016-02-29 | -$53.60M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$27.90M derived: sum of 2 quarters · filed 2016-02-29 | -$45.70M derived: sum of 3 quarters · filed 2016-02-29 | -$60.00M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$19.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$37.30M derived: sum of 2 quarters · filed 2014-11-07 | -$51.60M 10-Q · filed 2014-11-07 | -$79.10M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$17.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$32.10M 10-Q · filed 2014-08-08 | -$59.60M derived: sum of 3 quarters · filed 2015-02-27 | -$74.90M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$14.30M 10-Q · filed 2014-05-09 | -$41.80M derived: sum of 2 quarters · filed 2015-02-27 | -$57.10M derived: sum of 3 quarters · filed 2015-02-27 | -$75.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$42.80M derived: sum of 2 quarters · filed 2015-02-27 | -$60.70M derived: sum of 3 quarters · filed 2015-02-27 | -$93.20M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$33.20M derived: sum of 2 quarters · filed 2013-11-08 | -$65.70M 10-Q · filed 2013-11-08 | -$94.70M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$17.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$50.40M 10-Q · filed 2013-08-08 | -$79.40M derived: sum of 3 quarters · filed 2014-02-27 | -$86.60M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$32.50M 10-Q · filed 2013-05-09 | -$61.50M derived: sum of 2 quarters · filed 2014-02-27 | -$68.70M derived: sum of 3 quarters · filed 2014-02-27 | -$91.10M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$36.20M derived: sum of 2 quarters · filed 2014-02-27 | -$58.60M derived: sum of 3 quarters · filed 2014-02-27 | -$68.70M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$29.60M derived: sum of 2 quarters · filed 2012-11-08 | -$39.70M 10-Q · filed 2012-11-08 | -$280.40M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$22.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$32.50M 10-Q · filed 2012-08-09 | -$273.20M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2011-03-31 | -$10.10M 10-Q · filed 2012-05-09 | -$250.80M derived: sum of 2 quarters · filed 2013-02-28 | ||
| 2010-12-31 | -$240.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$299.00M 10-K · filed 2013-02-28 | ||
| 2010-09-30 | -$58.30M 10-Q · filed 2011-11-09 | |||
| 2009-12-31 | -$18.20M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |